All Industries

Top Biopharmaceutical Companies

13 Biopharmaceutical companies, sorted by total funding raised.

Arcellx
Acquired

Arcellx is a clinical-stage biopharmaceutical company developing novel, adaptive and controllable...

51–200Biopharmaceutical, Oncology
Seed·$375.0M·Jan 2024
Erytech
IPO

A clinical-stage biopharma company based in Lyon, France

Lyon, France51–200Biopharmaceutical, Therapeutics
Private Equity·$274.6M·Nov 2017
Inventiva Pharma
IPO

Clinical-stage biopharmaceutical company focused on the development of oral small molecule therap...

Daix, France51–200Biopharmaceutical, MASH Treatment
Growth Equity·$232.0M·May 2025
Centrexion Therapeutics

Centrexion Therapeutics Corp. is focused on advancing the treatment of chronic moderate to severe...

Boston, United States11–50Biopharmaceutical, CNS
Venture Round·$192.4M·Jun 2023
Addex Therapeutics
IPO

Addex Therapeutics is a biopharmaceutical company focused on the development of novel, orally ava...

Plan-les-Ouates, Switzerland11–50Biopharmaceutical, Biotech
Extension Round·$155.9M·Aug 2022
Ardelyx
IPO

Focused on the discovery and development of novel therapeutics acting exclusively in the gastroin...

Fremont, United States201–500Biopharmaceutical, Therapeutics
Private Equity·$140.0M·Jul 2016
Cadence Pharmaceuticals
Acquired

Hospital-focused biopharmaceutical company

San Diego, United States51–200Biopharmaceutical, Hospital
Series A·$86.6M·Feb 2009
Adimab

Provides antibody discovery and engineering services to biopharma partners using a yeast-based pl...

Lebanon, United States51–200Antibody Discovery, Biopharmaceutical
Series F·$26.0M·Jan 2012
Cerecor
Closed

Clinical stage biopharmaceutical company focused on the development of drugs to treat diseases of...

Baltimore, United StatesBiopharmaceutical, Biotech
Series A·$22.0M·Jan 2012
Akari Therapeutics
IPO

Biotechnology company developing advanced therapies for autoimmune and inflammatory diseases.

London, United Kingdom1–10Antibody-Drug Conjugates, Biopharmaceutical
Venture Round·$14.6M·Dec 2025
Complexa
Closed

Developing disease-modifying nitro fatty acid platform technology for patients with fibrosis and ...

Berwyn11–50Biopharmaceutical, Drug Development
Series C·Jul 2017
Annexon
IPO

Annexon Biosciences is leading the development of therapeutic products that halt the progression ...

South San Francisco, United StatesBiopharmaceutical, Healthcare
Series E·Nov 2025
Lumos Pharma
Merged

Developing a novel therapeutic for the rare disease Creatine Transporter Deficiency, an inborn er...

Austin, United States11–50Biopharmaceutical, Rare diseases
Series B·Apr 2016